Tenet Healthcare (THC) Tops Q4 EPS by 49c ; Offers Guidance

Tenet Healthcare (NYSE: THC) reported Q4 EPS of $3.44, $0.49 better than the analyst estimate of $2.95. Revenue for the quarter came in at $5.07 billion versus the consensus estimate of $5.17 billion.

GUIDANCE:

Tenet Healthcare sees FY2025 EPS of $11.74-$12.84, versus the consensus of $11.08. Tenet Healthcare sees FY2025 revenue of $20.6-21 billion, versus the consensus of $21.3 billion.

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Corning (GLW) files for up to $2B offering of common shares
• RH (RH) Tops Q2 EPS by $2.31
• Zumiez, Inc. (ZUMZ) Misses Q2 EPS by 6c, Misses on Revenue; Offers Q3 Guidance